Effect of cigarette smoke on UDP-glucuronosyltransferase activity and cytochrome P450 content in liver, lung and kidney microsomes in mice

Pharmacology and Toxicology

Volumn 82, Issue 2, 1998, Pages 74-79

  Villard, Pierre Henri ^a   Herber, Régine ^b   Sérée, Eric Marie ^a   Attolini, Laurence ^a   Magdalou, Jacques ^b   Lacarelle, Bruno ^a,c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Centre du Medicament URA CNRS 597   (France)

^c School of Pharmacy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; CYTOCHROME P450; GLUCURONOSYLTRANSFERASE; PHENOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCURONIDATION; KIDNEY MICROSOME; LIVER MICROSOME; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; NICOTIANA TABACUM;

EID: 0031933097     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01401.x     Document Type: Article

References (40)

1. Bansal, S. K. & T. Gessner: A unified method for the assay of uridine diphosphoglucuronosyltransferase activities towards various aglycones using uridine diphospho [U-14C] glucuronic acid. Anal. Biochem. 1980, 109, 321-329.
2. Bock, K. W., J. Wiltfang, R. Blume, D. Ullrich & J. Bircher: Paracetamol as a test drug to determine glucuronide formation in man. Effets of inducers and of smoking. Eur. J. Clin. Pharmacol. 1987, 31, 677-683.
3. Bock, K. W.: Roles of UDP-glucuronosyltransferases in chemical carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 1991, 26, 129-150.
4. Bock, K. W., D. Schrenk, A. Forster, et al.: The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes. Pharmacogenetics 1994, 4, 5163-5173.
5. Bradford, M. M.: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
6. Burchell, B. & W. H. Coughtrie: UDP-glucuronosyltransferases. Pharmacol. Therap. 1989, 43, 261-289.
7. Burchell, B., D. W. Nebert, D. R. Nelson, K. W. Bock, T. Iyanagi, P. L. Jansen, D. Lancet, G. J. Mulder, J. R. Chowdhury, G. Siest et al.: The UDP-glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol. 1991, 10, 487-494.
8. Czervinski, M., T. L. McLemore, H. V. Gelboin & F. J. Gonzalez: Quantification of CYP2B7, CYP4B1 and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res. 1994, 54, 1085-1091.
9. Denissenko, M. E., A. Pao, M. Tang & G. P. Pfeifer: Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996, 274, 430-432.
10. Dragacci, S., C. Hamar-Hansen, S. Fournel-Gigleux, C. Lafaurie, J. Magdalou J. & G. Siest: Comparative study of clofibric acid and bilirubin glucuronidation in human liver microsomes. Biochem. Pharmacol. 1987, 36, 3923-3927.
11. Gonzalez, F. J. & H. V. Gelboin: Role of humans cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev. 1994, 26, 165-183.
12. Grech-Belanger, O., J. Turgeon & M. Gilbert: Stereoselective disposition of mexiletine in man. Brit. J. Clin. Pharmacol. 1986, 21, 481-487.
13. Guengerich, F. P.: Analysis and characterization of enzymes. In: Principles and methods in toxicology. Ed.: A. W. Aayes. Raven Press, New York, 1989, pp. 777-814.
14. Guengerich, F. P., D. H. Kim & M. Iwasaki: Role of human cytochrome P450IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 1991, 4, 168-179.
15. Guengerich, F. P., T. Shimada, C. H. Yun, H. Yamazaki, K. D. Raney, R. Thier, B. Coles & T. M. Harris: Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes. Environ. Health Perspect. 1994, 102, 49-53.
16. Guengerich, F. P.: The 1992 Bernard B. Brodie Award Lecture. Bioactivation and detoxication of toxic and carcinogenic chemicals. Drug Metab. Disp. 1993, 21, 1-6.
17. I.A.R.C.: Monographs on the evaluation of the carcinogenic risk of chemicals to humans: Tobacco smoking. IARC Lyon, France, 1986.
18. International Organisation for Standardisation: Norm ISO 3308 Routine analytical cigarette-smoking machine. Definitions and standard conditions. ISO Genève, Switzerland, 1991.
19. Kawajiri, K., K. Nakachi, K. Imai, A. Yoshii, N. Shinoda & J. Watanabe: Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett, 1990, 263, 131-133.
20. Koop, D. R.: Oxidative and reductive metabolism by cytochrome P450IIE1. FASEB J. 1992, 6, 724-730.
21. MacDonald, J. I., R. J. Herman & R. K. Verbeeck: Sex-difference and the effects of smoking and oral contraceptive steroids on the kinetics of diflunisal. Eur. J. Clin. Pharmacol. 1990, 38, 175-179.
22. Magdalou, J., S. Fournel-Gigleux, H. Goudonnet, M. Pritchard & G. Siest: UDP-glucuronosyltransferase and peroxisome proliferators. In: Peroxisome proliferators: Unique inducers of drug metabolizing enzymes. CRC Press Inc., Boca Raton, FL, USA, 1994, 6, pp. 79-95.
23. Mayer, R. T., K. J. Netter, F. Heubel, B. Hahnemann, A. Buchheister, G. K. Mayer & M. D. Burke: 7-Alkoxyquinolines: new fluorescent substrates for cytochrome P450 monooxygenases. Biochem. Pharmacol. 1990, 40, 1645-1655.
24. McLemore, T. L., S. Adelberg, M. C. Liu, N. A. MacMahon, S. J. Yu, W. C. Hubbard, M. Czerwinski, T. G. Wood, Storeng, R. A. Lubet, J. C. Eggleston, M. R. Boyd & R. N. Hines: Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J. Natl. Cancer Inst. 1990, 82, 1333-1339.
25. Miners, J. O. & P. I. Mackenzie: Drug glucuronidation in humans. Pharmacol. Therap. 1992, 51, 347-369.
26. Mulder, G. J., M. W. H. Coughtrie & B. Burchell: Glucuronidation. In: Conjugation reactions in drug metabolism. Ed.: G. J. Mulder. Taylor & Francis, London, 1990 pp. 51-105.
27. Nash, T.: The colorimetric estimation of formaldehyde by means of the Hantzsh reaction. Biochem. 1953, 55, 416-421.
28. Nelson, D. R., T. Kamataki, D. J. Waxman, F. P. Guengerich, R. W. Estabrook, R. Feyereisen, F. J. Gonzalez, M. J. Coon, I. C. Gonzalus, O. Gotoh, K. Okuda & D. W. Nebert: The P450 super family: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993, 12, 1-51.
29. Omura, T. & R. Sato: The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 1964, 239, 2370-2378.
30. Parkinson, A.: Biotransformation of xenobiotics. In: Toxicology, the basic science of poison, 5th ed. Eds.: C. D. Klaasen, M. O. Amdur & J. Doull. McGraw-Hill Companies, U.S.A., 1996, pp. 113-186.
31. Peter, R., R. Bocker, P. H. Beaune, M. Iwasaki, F. P. Guengerich & C. S. Yang: Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem. Res. Toxicol. 1990, 3, 566-573.
32. Rogers, J. F., J. W. A. Findlay, J. H. Hull, R. F. Butz, E. C. Jones, J. A. Bustrack & R. M. Welch: Codeine disposition in smokers and nonsmokers. Clin. Pharmacol. Therap. 1982, 32, 218-227.
33. Safe, S. & V. Krishnan: Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Arch. Toxicol. 1994, 17, 99-115.
34. Schuetz, E. G., S. A. Wrighton, S. H. Safe & P. S. Guzelian: Regulation of cytochrome P450p by phenobarbital and phenobarbital-like inducers in adult rat hepatocytes in primary monolayer culture and in vivo. Biochem. 1986, 25, 1124-1133.
35. Shimada, T. & F. P. Guengerich: Activation of amino-alpha-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes. Cancer Res. 1991, 51, 5284-5291.
36. Siest, G., B. Antoine, S. Fournel, J. Magdalou & J. Thomassin: The glucuronosyltransferases: what progress can pharmacologists expect from molecular biology and cellular enzymology? Biochem. Pharmacol. 1987, 36, 983-989.
37. Van der Hoven, T. A. & M. J. Coon: Preparation and properties of partially purified cytochrome P450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P450 reductase from rabbit liver microsomes. J. Biol. Chem. 1974, 249, 6302-6310.
38. Walle, T., U. K. Walle, T. D. Cowart, E. C. Conradi & T. E. Gaffney: Selective induction of propanolol metabolism by smoking. Additional effects on renal clearance of metabolites. J. Pharmacol. Exp. Therap. 1987, 241, 928-933.
39. Villard, P. H., E. M. Sérée, B. Lacarelle, M. C. Théréné-Fénoglio, Y. Barra, L. Attolini, B. Bruguerole, A. Durand & J. Catalin: Effect of cigarette smoke on hepatic and pulmonary cytochromes P450 in mouse: evidence for CYP2E1 induction in lung. Biochem. Biophys. Res. Comm. 1994, 202, 1731-1737.
40. Wheeler, C.W., S. A. Wrighton & T. M. Guenthner: Detection of human lung cytochromes P450 that are immunochemically related to the cytochrome P450IIE1 and cytochrome P450IIIA. Biochem. Pharmacol. 1992, 44, 183-187.